Screener
Strata Critical Medical SRTA Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Strata Critical Medical’s reported figures.
Based on trailing twelve months.
The source filing: Strata Critical Medical’s 10-Q, filed November 10, 2025. Open the filing →
- Filed
- Nov 10, 2025
- Fiscal quarter
- Q3 FY2025
- Calendar quarter
- Q3 2025
- Accession
- 0001628280-25-050870
FAQ
- What is Strata Critical Medical's return on equity?
- Strata Critical Medical (SRTA) reported return on equity of 15.6% in Q3 2025.
- How has Strata Critical Medical's return on equity changed year-over-year?
- Strata Critical Medical's return on equity increased by 175.4% year-over-year, from -20.7% to 15.6%.
- What is the long-term trend for Strata Critical Medical's return on equity?
- Over 4 years (2020 to 2024), Strata Critical Medical's return on equity has grown at a -45.5% compound annual growth rate (CAGR), from -135.5% to -12%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about Strata Critical Medical's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude